The Medicines Company (MDCO) PT Raised to Street High $110 at Baird
Tweet Send to a Friend
Baird analyst Madhu Kumar raised the price target on The Medicines Company (NASDAQ: MDCO) to $110.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
